ALGAE
Research ALGAE on Bullrun: market cap EUR 54.62M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALGAE
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 54.62M
- Financial periodFY2025
- RevenueEUR 13.38M
- Revenue growth16.4%
- Net income-EUR 9.44M
- Free cash flow-EUR 8.12M
- Gross margin17.1%
Valuation Snapshot
latest market cap is EUR 54.62M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 13.38M | -EUR 9.44M | -EUR 8.12M | 17.1% | -0.09 | EUR 6.62M | EUR 5.02M | EUR 25.18M |
| FY2024 | EUR 11.50M | -EUR 12.88M | -EUR 2.00M | 21.7% | -0.17 | EUR 20.58M | EUR 12.60M | EUR 32.76M |
| FY2023 | EUR 4.06M | -EUR 14.15M | -EUR 11.09M | 13.2% | -0.32 | EUR 11.16M | EUR 15.35M | EUR 30.85M |
| FY2022 | EUR 7.65M | -EUR 9.87M | -EUR 13.38M | 23.8% | -0.24 | EUR 15.90M | EUR 11.02M | EUR 41.98M |
| FY2021 | EUR 5.65M | -EUR 6.85M | -EUR 11.72M | 35.1% | -0.19 | EUR 26.01M | EUR 9.61M | EUR 47.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 54.62M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ALGAE
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ALGAE's market cap?
ALGAE's market capitalization is EUR 54.62M.
What does ALGAE do?
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.